The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Cited by (847)

Items 601–700 of 847

  1. Immunometabolic Dysregulation in B-Cell Acute Lymphoblastic Leukemia Revealed by Single-Cell RNA Sequencing: Perspectives on Subtypes and Potential Therapeutic Targets
    Dingya Sun, Dun Hu, Jialu Wang, Jun Peng, Shan Wang · 2025 · International Journal of Molecular Sciences
  2. Circadian engineering of in vivo CAR T cell therapy for precision oncology
    Jhommara Bautista, Carolina E. Echeverría, María Gabriella Rodríguez-Marcano, Andrés López-Cortés · 2026 · npj Precision Oncology
  3. Changes in tumor and cardiac metabolism upon immune checkpoint
    Anna‐Sophia Leven, Natalie Wagner, Stephan Nienaber, Daniel Messiha, Alpaslan Tasdogan, Selma Ugurel · 2024 · Basic Research in Cardiology
  4. Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma
    Ciara Louise L. Freeman, Julieta Abraham-Miranda, Meghan A. Menges, Reginald M. Atkins, Jerald D. Noble, Hien D. Liu, Salvatore A. Corallo, Luis A. Cuadrado Delgado, Albert J Ribickas, Constanza Savid-Frontera et al. · 2025 · Molecular Therapy
  5. Tumor microenvironment and metabolic reprogramming: Unraveling the complex interplay in gastrointestinal tumor liver metastasis
    Song Wang, Zheng Ma, Lizhi Lv, Yu Qian, Shanglong Liu, Yun Lu · 2025 · Critical Reviews in Oncology/Hematology
  6. A reengineered common chain cytokine augments CD8+ T cell–dependent immunotherapy
    Anirban Banerjee, Dongge Li, Yizhan Guo, Zhongcheng Mei, Christine L. Lau, Kelly Chen, John K. Westwick, Jeffery B. Klauda, Adam G. Schrum, Eric Lazear et al. · 2022 · JCI Insight
  7. Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases
    Shingo Takada, Shintaro Kinugawa, Haruka Handa, Takashi Yokota, Hisataka Sabe · 2022 · Frontiers in Oncology
  8. Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer
    Ren-Jie Xia, Xiaoyu Du, Li-Wen Shen, Jianguo Ma, Shumei Xu, Rui-Fang Fan, Jian-Wei Qin, Long Yan · 2024 · World Journal of Gastrointestinal Oncology
  9. The Bidirectional Interplay between T Cell–Based Immunotherapies and the Tumor Microenvironment
    Alfredo Pherez-Farah, Gioia Boncompagni, Aleksey Chudnovskiy, Giulia Pasqual · 2025 · Cancer Immunology Research
  10. T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
    Qingxiu Xu, Le Li, Rongfei Zhu · 2025 · Current Allergy and Asthma Reports
  11. The Clinical Use of Hydrogen as a Medical Treatment
    Yunbo Xie, Guohua Song · 2024 · Advances in biochemistry in health and disease
  12. Global Immunometabolic Profiling of AECOPD
    Dongli Song, Fangming Liu, Bijun Zhu, Jun Yin, Zhongshu Kuang, Zhimin Dong, Lei Yan, Ling Ye, Yong Zhang, Zhenju Song et al. · 2020 · Small Methods
  13. Metabolomic Profiling Reveals Potential of Fatty Acids as Regulators of Stem-like Exhausted CD8 T Cells During Chronic Viral Infection
    Katelynn R. Kazane, Lara Labarta-Bajo, Dina Zangwill, Kalle Liimatta, Fernando Vargas, Kelly C. Weldon, Pieter C. Dorrestein, Elina I. Zúñiga · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Peripheral CX3CR1 + T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer
    Congcong Li, Zhen Zhang, Qianfeng Cai, Qitai Zhao, Han Wu, JunRu Li, Yaqing Liu, Xuan Zhao, Jinyan Liu, Ping Yü et al. · 2024 · OncoImmunology
  15. Differentiation and mitochondrial metabolic characteristics of CD8+ T cells in malignant ascites of epithelial ovarian cancer and their correlation with estrogen signaling
    Zouyu Jiang, Ying Zhou, Jia-juan Wu, Yu Shen, Danni Tang, Yuhong Wu, Qiu‐Xia Qu, Juan Wang · 2025 · Cancer Immunology Immunotherapy
  16. Glutamine synthetase deficiency enhances CD8 T cell survival and stress resilience in the tumor microenvironment
    Emilie L. Fisher, Emma S. Hathaway, Jeffrey M Perera, Erin Q. Jennings, Channing Chi, Allison E. Sewell, Spenser H Stone, Jason E. Muka, Rachael C. Sinard, Joseph A. DeCorte et al. · 2025 · The Journal of Immunology
  17. A pancancer analysis reveals the oncogenic role of glutaminase 1 (GLS1) in tumor metabolism and immune evasion: a bioinformatics analysis
    Jianjun Liu, Shikai Hong, Kangsheng Gu · 2025 · Discover Oncology
  18. The multifaceted landscape of T cell exhaustion in organ transplantation: From molecular mechanisms (epigenetics, transcription, metabolism) to induction strategies
    Yining Wang, You Wu, Yufei Shen, Yujia Chen, Yifan Zhao, Xiandong Zeng, Kang He · 2025 · Genes & Diseases
  19. Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox
    Guoxiao Han, Shuyu Yuan, WANGUI YU · 2026 · Metabolites
  20. Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity
    Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola, Paloma Velasco-Beltrán, Leire Egia‐Mendikute, Borja Jiménez-Lasheras, Alexandre Bosch, Adrián Barreira-Manrique, Iker Oyenarte, So Young Lee et al. · 2026 · Cancer Research
  21. T cell exhaustion landscapes and therapeutic modulation in cancer immunity
    Jhommara Bautista, Andrés López‐Cortés · 2026 · Frontiers in Cell and Developmental Biology
  22. T-cell exhaustion in tumor immunology: mechanisms, heterogeneity, and therapeutic strategies
    Ruoxuan Wang, Yingjie Guo · 2026 · Frontiers in Immunology
  23. Nanomodulation and nanotherapeutics of tumor-microenvironment
    Rupal Dubey, Sourbh Suren Garg, Jeena Gupta · 2022 · OpenNano
  24. Tissue-Resident Memory T Cells in Tumor Immunity and Immunotherapy of Digestive System Tumors
    Min Cheng, Jie Liu, Yue Liang, Jiamei Xu, Lin Ma, Jing Liang · 2025 · Immunological Investigations
  25. Metabolic profiling of antigen-specific CD8+ T cells by spectral flow cytometry
    Nils Mülling, J. Fréderique de Graaf, Graham A. Heieis, Kristina Boss, Benjamin Wilde, Bart Everts, Ramon Arens · 2025 · Cell Reports Methods
  26. Oxidative Stress in the Tumor Immune Microenvironment
    Yuexi Wang, Yanan Hu, Yuting Jiang, Shengtao Zhou · 2021 · Springer eBooks
  27. TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
    Rebecca S. Hesterberg, Min Liu, Aya G. Elmarsafawi, John M. Koomen, Eric A. Welsh, Stephen G. Hesterberg, Sujeewa Ranatunga, Chunying Yang, Weimin Li, Harshani R. Lawrence et al. · 2022 · Cancer Immunology Research
  28. Laparoscopic-Assisted Colorectal Resection Can Reduce the Inhibition of Immune Function Compared with Conventional Open Surgery: A Retrospective Clinical Study
    Bo Shi, Qingliang Tai, Junjie Chen, Xinyu Shi, Guoliang Chen, Huihui Yao, Xiuwei Mi, Jinbing Sun, Guoqiang Zhou, Wen Gu et al. · 2023 · Journal of Clinical Medicine
  29. Eradication of tumors with pre-existing antigenic heterogeneity by vaccine-mediated co-engagement of CAR T and endogenous T-cells
    Leyuan Ma, Duncan M. Morgan, Ina Sulkaj, Parisa Yousefpour, Charles A. Whittaker, Wuhbet D. Abraham, Na Li, John Christopher Love, Darrell J. Irvine · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  30. A balanced CAR-T cell metabolism driven by CD28 or 4-1BB co-stimulation correlates with clinical success in lymphoma patients
    Molly S. Cook, Katie R. Flaherty, Sophie Papa, Reuben Benjamin, Anna Schurich · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Immunometabolism in cancer: A journey into innate and adaptive cells
    Alexia Nedel Sant’Ana, Camila Kehl Dias, Sacha Krolow e Silva, Fabrício Figueiró · 2024 · International Reviews of Immunology
  32. Nanomaterials Trigger Functional Anti‐Tumoral Responses in Primary Human Immune Cells
    Vincent Mittelheisser, Olivier Lefèbvre, Mainak Banerjee, Shayamita Ghosh, Amandine Dupas, Marie‐Charlotte Diringer, Juliette Blumberger, Louis Bochler, Sébastien Harlepp, Annabel Larnicol et al. · 2025 · Advanced Science
  33. Mitochondrial Activity Regulates Human T Helper 17 Differentiation and Function
    Xinlai Chen, Theodoros Ioannis Papadimitriou, A. Essen, Britt van Brunschot, Monique M. A. Helsen, Annet W Sloetjes, E.L. Vitters, Werner J.H. Koopman, Peter M. van der Kraan, A. van Caam et al. · 2025 · Immunology
  34. Mitochondria-containing large extracellular vesicles target mouse motor neurons upon intramuscular injection
    Paromita Paul Pinky, Zhong-Min Wang, Purva Khare, Jhanvi R Jhaveri, Abigail Sullivan, Vivek Basudkar, Krithika Rao, Audrey Lawrence, Adithri Pingali, Kandarp M. Dave et al. · 2025 · Extracellular Vesicle
  35. CD8+ T cell aging, senescence, and related disease
    Zhe He, Fei Guo, Qifan Zhao, Wei Lu · 2026 · Science China Life Sciences
  36. Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA
    Lance A. Johnson, Kai Saito, Akhil V. Pallerla, Jessica L. Funnell, Ashley R. Ezzo, Chelsea M. Song, Douglas A. Harrison, Noah J. Norton, Lauren C. Moore, Linda J. Van Eldik et al. · 2026 · Nature Communications
  37. Strategies and mechanisms for the enhancement of chimeric antigen receptor T-cell functions
    Shi Zhong Han, Juan Yue, Haiqiong Zheng, Yue Huang, Delin Kong, Guoqing Wei, Yongxian Hu, He Huang · 2026 · Science China Life Sciences
  38. Targeting metabolic reprogramming to enhance adoptive immunotherapy: emerging mechanisms and translational perspectives
    Liu Yang, Chengyu Zhang, Zhongxiang Zhang, Songlin Yao, Jing Shen, Zhuo Zhang, Zhangang Xiao, Shurong Wang, Zhigui Wu · 2026 · Journal of Translational Medicine
  39. Myeloid-derived immunosuppression of chimeric antigen receptor T cells in the neuronal microenvironment of glioblastoma
    Junyi Zhang, Jasmin von Ehr, Thomas Look, Jasim Kada Benotmane, Nicolas Noel Neidert, Jan Kueckelhaus, Tobias Weiß, Dieter Henrik Heiland, Yahaya Abubakar Yabo · 2026 · BMC Medicine
  40. Lisocabtagene maraleucel outcome in large B-cell lymphoma associates with memory composition and mitochondrial fitness of T cells
    Chaja Feige Jacobs, Helga Simon‐Molas, Gaspard Cretenet, Miriam V. Gutschow, Garrett Collett, Lucrezia Colonna, Ken Ogasawara, Lara P. Stepan, Kien Khuu-Duong, Arnon Philip Kater et al. · 2026 · Blood Immunology & Cellular Therapy
  41. Transcriptomic evidence of CD8⁺ T-cell exhaustion-like phenotype and mitochondrial impairment underlying immune dysregulation in feline chronic gingivostomatitis
    Maria M. Soltero‐Rivera, Patrawin Wanakumjorn, Yihong Chen, Samantha M. Barnum, Luis Diego Castillo Charpentier, Boaz Arzi, N. Vapniarsky-Arzi, Amir Kol · 2026 · Scientific Reports
  42. Mitochondrial transfer-driven immune evasion in the tumor microenvironment
    Li Zhu, Yosuke Togashi · 2026 · International Immunology
  43. Next-generation CAR-T combinations: Integrating nanomedicine, metabolic reprogramming, and AI for solid tumor targeting
    S R Krupesha Sharma, Sobin Saha, Swati Arora, Yogesh K Ahlawa, Sumit Sheoran, Srestha Mukherjee, Astha Sinha, Kirti Chaudhary, Sunil Babu Gosipatala · 2026 · Disease and Therapeutics
  44. Mitochondrial transfer in the tumor microenvironment: a dynamic determinant of cancer plasticity, immune dysfunction, and therapeutic opportunity
    Zhenyuan Xu, Qingli Zhou, Jifei Miao · 2026 · Frontiers in Immunology
  45. Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming
    Wentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong · 2026 · Frontiers in Immunology
  46. Autophagy in thyroid cancer: Immune suppression and drug resistance
    Huan Zhai, Peng Sun, Bushra Bashir, Bicheng Qu, Zhenfang Du, Alan Prem Kumar, Yonghui Xia, Prakash Gangadaran, Saurabh Kumar Jha, Sachin Kumar Singh et al. · 2026 · Drug Resistance Updates
  47. CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions
    Duc‐Hiep Bach, V. Huy Hoang, Thi Viet Pham, Huong, Dinh Duy Nguyen · 2026 · Cancer Cell International
  48. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer
    Haishan Lin, Bangwei Cao · 2022 · Disease Markers
  49. Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review
    Janet Yuling Wu, Alexander Liang Ren, Michael K. Lim · 2022 · Chinese Clinical Oncology
  50. Ubiquitination in the T Cell Metabolism-Based Immunotherapy in Diseases
    Ke-qi Fan, Yi‐yuan Li, Jin Jin · 2024 · Advances in experimental medicine and biology
  51. Vol 15 Issue 1 Tumor Microenvironment-Different Cells and Functions in the Metastasis and Progression of Cancer
    Maryam Musleh Althobiti · 2024 · International Journal of Pharmaceutical Investigation
  52. Loss of ten-eleven translocation 2 (TET2) facilitates aggressive behaviour in cutaneous melanoma by inducing peroxisome proliferator-activated receptor-γ coactivator 1α expression and oxidative phosphorylation
    Grant M. Fischer, Rui Fang, Shuyun Xu, Anastasia Iris Karkempetzaki, Laure Migayron, Elizabeth C. Draper, Justina Wang, Tobias Schatton, Anna Mandinova, George F Murphy et al. · 2025 · British Journal of Dermatology
  53. Immune Cell Metabolic Fitness for Life
    Kevin S. Bittman · 2022 · Antibodies
  54. Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma
    Xing Feng Huang, Li Sheng Fu, Qian Cai, Fei Fan · 2023 · Frontiers in Oncology
  55. A Novel Strategy to Fuel Cancer Immunotherapy: Targeting Glucose Metabolism to Remodel the Tumor Microenvironment
    Xu Liu, Yujie Zhao, Xi Wu, Zhihui Liu, Xiaowei Liu · 2022 · Vide Leaf, Hyderabad eBooks
  56. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity
    Taylor L. Hickman, Eugene Choi, Kathleen R. Whiteman, Sujatha Muralidharan, Tapasya Pai, Tyler Johnson, Avani Bharat Parikh, Taylor Friedman, Madaline Gilbert, Binzhang Shen et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Nanomaterials trigger functional responses in primary human immune cells
    Vincent Mittelheisser, Olivier Lefèbvre, Mainak Banerjee, Shayamita Ghosh, Amandine Dupas, Marie‐Charlotte Diringer, Juliette Blumberger, Louis Bochler, Sébastien Harlepp, Annabel Larnicol et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Mechanism of oxidative stress in carcinogenesis induced by xenobiotics
    Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Ramesh Singh, Rajesh Kumar Singh · 2022 · Elsevier eBooks
  59. Exhaustion‐Resistant CD8 + T Cells in Ankylosing Spondylitis: A Proposed Three‐Axis Model
    Xuhong Zhang, Jia Lu, Xueni Lin, Lamei Zhou · 2025 · Immunology
  60. T-Cell Exhaustion in Cancers
    Kiarash Saleki, Nima Rezaei · 2025 · Springer eBooks
  61. Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis
    Shabnam Varmazyari, Hossein Borhani, Zohreh Moradipour, Heliya Ziaei, Nima Rezaei · 2025 · Advances in experimental medicine and biology
  62. Tumor-associated disruption of T cell receptor signaling: lessons across cancers with implications for CLL
    Carlota Lopez-Sanchez, Jaco A. C. van Bruggen, Arnon Philip Kater · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
  63. New insight into the risk stratification and treatment priority of breast cancer: TMT scoring system
    Zhe Qi, Yuechao Yang, Zhisu Wang, Sen Li, Deheng Li, Lei Chen, Mingtao Feng, Changshuai Zhou, Xin Chen, Bin Hao et al. · 2025 · International Journal of Surgery
  64. Metabolic Reprogramming of Adaptive Immunity Induced by Viral Infections
    Guoshuai Tong, Jingwen Dai, Qianqian Liu, Xu Gao, Su Li, Hua‐Ji Qiu · 2025 · Immunology
  65. Multiple myeloma derived sulfur dioxide drives CAR-T cell exhaustion by inducing mitochondrial dysfunction
    Zhengyu Yu, Hua Lin, Jingran He, Linfeng Li, Zhongwang Wang, Kun Li, Ting Niu, Bingquan Qiu · 2026 · Redox Biology
  66. Innate lymphoid cells as emerging players in cancer immunotherapy
    Deyuan Kong, Yun Chen · 2026 · EngMedicine
  67. CX3CR1 identifies a potent effector CD8+ T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancer
    Jiajin Ma, Yue Wu, Rongzhang Chen, Nuo Wang, Yirui Liu, L. Chen, Shaoxian Wu, Xiao Wei Zheng · 2026 · Frontiers in Immunology
  68. Cancer mtDNA mutations: metabolic plasticity and therapeutic promise?
    Ersong Shang, Omar Aftab, Abbienaya Dayanamby, Laura C. Greaves · 2026 · Trends in Molecular Medicine
  69. Multifunctional Role of Mitochondrial Fatty Acid Oxidation in Cancer Immunotherapy and Aging
    Koji Kitaoka, Shuhei Hirose, Yu Wang, Tomonori Yaguchi, Kenji Chamoto · 2026 · Cancer Science
  70. Supercharging the metabolic engine: mitochondrial engineering strategies for CAR-T persistence in solid tumors
    Soohyun Chun, Sanghyeon Yu, Hyun Gu Lee, Man Soo Kim · 2026 · Frontiers in Immunology
  71. T‐Cell Exhaustion in the Tumor Microenvironment: Subcellular Dysfunction, Pan‐Cancer Characteristics, and Therapeutic Interventions
    Mingxing Wang, Wanhui Dong, Jian Chen, Zhangjie Zhou, Shujuan Fu, Tingting Wu, Haiyan Jiang, Z Wang, Zhixian Zhong, Yi Zhong · 2026 · Advanced Science
  72. MTFR2 promotes VDAC1 oligomerization to reprogram BCAA metabolism in tumor cells to polarize TAMs in LUAD
    Yutong Ge, Tao Yu, Shaokun Yu, Ao Sun, Shiyu Zhang, Meiling Zhang, Qian Wang, Jia Liu, Xuan Zhang, Lulin Zeng et al. · 2026 · Cell Death and Disease
  73. Mitochondrial Stress Orchestrates Tumor Immune Evasion and Immunotherapy Resistance
    Ayhan Bılır, Berna Yıldırım, Mete Hakan Karalök · 2026 · Cells
  74. Engineering T cell metabolism to enhance therapeutic efficacy
    Laura Anderson, Nicola J. Mason, Roddy S. O’Connor · 2026 · Advances in pharmacology
  75. Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy
    Paul Lindau, Alex V. Nesta, Caroline E. Roe, Madelyn D. Landis, Zaid Hatem, Allison E. Sewell, Allison K Blount, Jackie E. Bader, Reddy Anupama, W. Kimryn Rathmell et al. · 2026 · The Journal of Immunology
  76. Modulating CAR-T cell exhaustion and fitness in acute myeloid leukemia: mechanistic metabolic and microenvironmental strategies
    Erden Atilla · 2026 · Frontiers in Immunology
  77. Metabolic transcriptomic subtyping defines distinct immunogenomic and clinical landscapes in non–small cell lung cancer
    Seo-Young Lee, Heesun Cheong, Seog-Yun Park, Sohyun Park, Jinju Pak, Youngjoo Lee · 2026 · npj Precision Oncology
  78. Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cells
    Luis Felipe Olguín-Contreras, Johanna Heep, Lisa Schiller, Eva Loffredo‐Verde, Marvin M. Festag, Metzger Kai, Stephanie Färber, Merve Gültan, Margaret Tulessin, Susanne Wilde et al. · 2026 · Frontiers in Immunology
  79. Mitochondrial transfer in cancer: a global bibliometric analysis
    Lu Yang, Liangkai Zhu, Yan Xu, Sihong Ye, Yana Wang, Baicheng Ni, Ming Zheng, W-Z Chen · 2026 · Frontiers in Oncology
  80. Metabolic reprogramming networks in the gastric cancer tumor microenvironment: an integrated axis of nutrient competition, metabolic crosstalk, and immunosuppression
    Xiaona He, Jun Liu, Wenjie Wang · 2026 · Frontiers in Immunology
  81. Circadian rhythm, oxidative stress, and cancer immunosuppression
    YJ Li, Eugenie Nepovimová, Qinghua Wu, Kamil Kuča · 2026 · Archives of Toxicology
  82. Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response
    João S. Patrício, Cindy Mendes, Paulo A. Gameiro · 2026 · Advances in experimental medicine and biology
  83. Metabolic cell competition in the glioblastoma tumour microenvironment: glucose, glutamine, and lactate as determinants of immune exclusion and targets for pharmacological reprogramming
    Egiroh Omene · 2026 · Frontiers in Oncology
  84. Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
    Na Li, Shurong Li, Peng Cao, Mengfan Tang, Junfeng Zhang, Wei Kevin Zhang, Jinfeng Liu, Chunping Ye, Dan Wu, Xixi Li et al. · 2026 · Cancer Gene Therapy
  85. Targeting T-cell exhaustion and tumour immune evasion: a review of emerging strategies
    Leticija Saltis, Liew Jun Mun · 2026 · Pathology - Research and Practice
  86. Mitochondrial transfer in the tumor microenvironment: Mechanisms, immunometabolic consequences, and therapeutic implications
    Sijia Feng, Yanan Hu, Shuqing Li, 常玉巧, Zhenwei Li, Yanting Liu, Kai Xu · 2026 · Critical Reviews in Oncology/Hematology
  87. Two is Better Than One: Advances in Pathogen-Boosted Immunotherapy and Adoptive T-Cell Therapy
    Gang Xin, David Schauder, Ryan Zander, Weiguo Cui · 2017 · Immunotherapy
  88. Metabolic aspects of adoptive immunotherapy of tumors
    D. B. Kazanskiy, Yu. Yu. Silaeva, Anastasiia A. Kalinina, Maria A. Zamkova, Ludmila M. Khromykh, Персиянцева Надежда Александровна, L. Kh. Dzholokhava · 2017 · Advances in molecular oncology
  89. Analyzing Melanoma Cell Oxygen Consumption and Extracellular Acidification Rates Using Seahorse Technology
    Ashley V. Menk, Greg M. Delgoffe · 2021 · Methods in molecular biology
  90. Advances in research on glioma microenvironment and immunotherapeutic targets
    Aiwei Tang, Jianhao Liang, Yiying Mai, Haitao Sun · 2022 · Journal of Cancer Discovery
  91. PTEN checkMAITs type-17 innate-like T cells
    Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2022 · Nature Cell Biology
  92. CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling
    Xiaoying Zhu, Zhaodong Zhong, Fankai Meng, Ping Zou, Yong Hua You, Qing Li, Xiaojian Zhu · 2023 · Immunopharmacology and Immunotoxicology
  93. Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma
    Zhihao Wei, Chenchen Liu, Jiaqian Liang, Xuan Zhou, Kaming Xue, Keshan Wang, Xiaoping Zhang · 2024 · IUBMB Life
  94. A Pipeline for Dynamic Analysis of Mitochondrial Content in Developing T Cells: Bridging the Gap Between High-Throughput Flow Cytometry and Single-Cell Microscopy Analysis
    Vaibhav Dhyani, Anchi S. Chann, Lopamudra Giri, Sarah May Russell, Mirren Charnley · 2024 · Methods in molecular biology
  95. Metabolic Checkpoint of Immune Cells in Melanoma Brain Metastases
    Colt A. Egelston, Kim Allyson Margolin · 2019 · Cancer Discovery
  96. Harnessing metabolism for reinvigorating dysfunctional T cells in cancer
    Susana Romero‐Garcia, Daniela Alejandra Castro‐Flores, Heriberto Prado-García · 2021 · Elsevier eBooks
  97. Tumor hypoxia drives suppressor function in exhausted T cells limiting antitumor immunity
    Greg M. Delgoffe, Paolo Vignali, Kristin DePeaux, McLane J. Watson, Konstantinos Lontos, Nicole McGaa, Nicole E. Scharping, Ashley V. Menk · 2021 · Research Square
  98. The coenzyme A precursor pantethine restrains sarcoma growth through promotion of type 1 immunity
    Richard MIALLOT, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Jean‐Charles Martin, Laetitia Shintu, Paul BERCHARD, Juliane Sousa Lanza, Bernard MALISSEN et al. · 2022 · Research Square
  99. Editorial: T cell exhaustion; mechanisms of induction, modulation, and recovery
    Mohamed S. Abdel-Hakeem · 2023 · Frontiers in Immunology
  100. Cancer immunotherapies
    Femke A. I. Ehlers · 2023 · Research Publications (Maastricht University)